| 股號 / 名稱 | 營收 | 稅後淨利 |
| ABT 美國雅培 | 9,964,000,000.0 | 1,225,000,000.0 |
| MDT 美敦力 | 8,089,000,000.0 | 1,337,000,000.0 |
| SYK 史賽克 | 5,243,000,000.0 | 788,000,000.0 |
| BSX Boston Scientific Corp | 3,856,000,000.0 | 493,000,000.0 |
| OMI Owens & Minor Inc | 2,612,680,000.0 | -21,886,000.0 |
| ZBH Zimmer Biomet Holdings Inc | 1,889,200,000.0 | 172,800,000.0 |
| RMD 瑞思邁 | 1,196,980,000.0 | 300,492,000.0 |
| QDEL QuidelOrtho Corp | 742,600,000.0 | 7,000,000.0 |
| BIO Bio Rad Laboratories Inc | 681,184,000.0 | 349,708,000.0 |
| NVST Envista Holdings Corp | 623,600,000.0 | 23,600,000.0 |
| ICUI ICU Medical Inc | 587,856,000.0 | -17,147,000.0 |
| EYE National Vision Holdings Inc | 506,403,000.0 | -15,987,000.0 |
| BRBR Bellring Brands Inc | 494,600,000.0 | 57,200,000.0 |
| HCM HUTCHMED (China) Ltd | 305,125,000.0 | -68,374,000.0 |
| PAHC Phibro Animal Health Corp | 249,943,000.0 | 1,274,000.0 |
| NEOG Neogen Corp | 228,812,000.0 | -2,022,000.0 |
| PETQ PetIQ Inc | 219,926,000.0 | -17,251,000.0 |
| WRBY Warby Parker Inc | 161,855,000.0 | -19,047,000.0 |
| ATRC AtriCure Inc | 108,851,000.0 | -13,269,000.0 |
| INMD Inmode Ltd | 80,284,000.0 | 23,696,000.0 |
| MRVI Maravai LifeSciences Holdings Inc | 74,141,000.0 | -109,982,000.0 |
| QIPT Quipt Home Medical Corp | 65,363,000.0 | -586,000.0 |
| TGTX TG Therapeutics Inc | 63,474,000.0 | -10,707,000.0 |
| EOLS Evolus Inc | 60,999,000.0 | -11,831,000.0 |
| CERS Cerus Corp | 53,342,000.0 | -1,389,000.0 |
| VMD Viemed Healthcare Inc | 50,593,000.0 | 1,603,000.0 |
| ZYXI Zynex Inc | 46,531,000.0 | 10,000.0 |
| ZVIA Zevia PBC | 37,794,000.0 | -9,151,000.0 |
| BLFS BioLife Solutions Inc | 32,733,000.0 | -13,382,000.0 |
| SRDX Surmodics Inc | 31,958,000.0 | 247,000.0 |
| QTRX Quanterix Corp | 31,549,000.0 | -12,409,000.0 |
| RMTI Rockwell Medical Inc | 22,093,000.0 | -1,512,000.0 |
| FLGC Flora Growth Corp | 17,975,000.0 | -7,121,000.0 |
| APYX Apyx Medical Corp | 14,662,000.0 | -9,624,000.0 |
| XGN Exagen Inc | 13,765,000.0 | -5,573,000.0 |
| TRIB Trinity Biotech PLC | 13,428,000.0 | -5,498,000.0 |
| UTMD Utah Medical Products Inc | 12,333,000.0 | 4,286,000.0 |
| CAPR Capricor Therapeutics Inc | 12,088,090.0 | -762,090.0 |
| MGNX MacroGenics Inc | 10,720,000.0 | -46,073,000.0 |
| LFLY Leafly Holdings Inc | 9,745,000.0 | -455,000.0 |
| CTSO Cytosorbents Corp | 8,668,220.0 | -5,834,910.0 |
| ICCC ImmuCell Corp | 5,095,960.0 | -1,139,830.0 |
| NEPH Nephros Inc | 3,254,000.0 | -654,000.0 |
| GHSI Guardion Health Sciences Inc | 2,935,860.0 | 424,720.0 |
| UG United-Guardian Inc | 2,607,010.0 | 737,440.0 |
| VERU Veru Inc | 2,140,730.0 | -8,275,980.0 |
| NURO NeuroMetrix Inc | 1,317,750.0 | -1,649,550.0 |
| SNES Senestech Inc | 295,000.0 | -1,733,000.0 |
| GCTK GlucoTrack Inc | 0.0 | -2,412,000.0 |
| OMER Omeros Corp | 0.0 | -39,287,000.0 |
| HUGE FSD Pharma Inc | 0.0 | -1,651,570.0 |
| CMRX Chimerix Inc | 0.0 | -21,869,000.0 |
| CLRB Cellectar Biosciences Inc | 0.0 | -7,448,660.0 |
| ORMP Oramed Pharmaceuticals Inc | 0.0 | 13,296,000.0 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股營收排名、龍頭是誰？
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例